Predictive Value of GJB2 Mutation Status for Hearing Outcomes of Pediatric Cochlear Implantation

Objective To systematically review and quantify current evidence regarding the association of GJB2 mutation status with outcomes of pediatric cochlear implantation. Data Sources PubMed, Embase, and the Cochrane Library were searched for “GJB2,”“pediatric hearing loss,” and “cochlear implantation” and their synonyms, with no language restrictions, until December 2, 2015. Review Methods Studies were included that investigated the status of GJB2 mutation and its predictive value for outcomes of pediatric cochlear implantation. Speech recognition scores, Infant-Toddler Meaningful Auditory Integration Scale, Speech Intelligibility Rating, and Categorized Auditory Performance were pooled using weighted mean differences, and a 95% confidence interval. Results Eighteen studies met the inclusion criteria. The differences between GJB2-related deafness and non-GJB2-related deafness due to unidentified causes and other types of genetic deafness without additional disabilities were not statistically significant (P = .15 and P = .30, respectively); however, the difference between GJB2-related deafness and acquired hearing loss due to environmental etiologies was statistically significant and favored GJB2-related deafness (P = .03). Conclusion GJB2-related deafness leads to significantly better cochlear implantation outcomes when compared with acquired deafness caused by environmental etiologies. However, GJB2 mutation is not associated with a significantly better prognosis when compared with those whose deafness results from either nonsyndromic hearing loss of unknown origin or other types of genetic mutations in the absence of other neurologic deficits.

[1]  M. Kalcıoğlu,et al.  Genetics of Nonsyndromic Congenital Hearing Loss , 2016, Scientifica.

[2]  C. Megerian,et al.  Predictive factors and outcomes of cochlear implantation in patients with connexin 26 mutation: a comparative study. , 2015, American journal of otolaryngology.

[3]  E. Sukarova-Stefanovska,et al.  Speech Perception Outcomes after Cochlear Implantation in Children with GJB2/DFNB1 associated Deafness. , 2014, Balkan medical journal.

[4]  Xue Gao,et al.  [Assessment of the curative effective of cochlear implantation in childer with GJB2-associated NSSNHL]. , 2014, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[5]  T. Strom,et al.  Genetic Spectrum of Autosomal Recessive Non-Syndromic Hearing Loss in Pakistani Families , 2014, PloS one.

[6]  D. Gašperíková,et al.  Is deafness etiology important for prediction of functional outcomes in pediatric cochlear implantation? , 2014, Acta oto-laryngologica.

[7]  Y. Kanda,et al.  Long term speech perception after cochlear implant in pediatric patients with GJB2 mutations. , 2013, Auris, nasus, larynx.

[8]  Hong-Bo Zhao,et al.  Active cochlear amplification is dependent on supporting cell gap junctions , 2013, Nature Communications.

[9]  M. Torrente,et al.  Prevalence of the 35delG mutation in the GJB2 gene in two samples of non-syndromic deaf subjects from Chile. , 2013, Biological research.

[10]  X. Liu,et al.  Influence of DFNB1 Status on Expressive Language in Deaf Children With Cochlear Implants , 2011, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[11]  Y. Bayazıt,et al.  Association of GJB2 gene mutation with cochlear implant performance in genetic non-syndromic hearing loss. , 2011, International journal of pediatric otorhinolaryngology.

[12]  H. Salmasian,et al.  Clinical Application of Screening for GJB2 Mutations before Cochlear Implantation in a Heterogeneous Population with High Rate of Autosomal Recessive Nonsyndromic Hearing Loss , 2011, Genetics research international.

[13]  Chuan-Jen Hsu,et al.  Genetic characteristics in children with cochlear implants and the corresponding auditory performance , 2011, The Laryngoscope.

[14]  M. Farhadi,et al.  Prevalence of GJB2-associated deafness and outcomes of cochlear implantation in Iran , 2011, The Journal of Laryngology & Otology.

[15]  F. Honegger,et al.  High homogeneity in auditory outcome of pediatric CI-patients with mutations in Gap-Junction-Protein Beta2. , 2010, International journal of pediatric otorhinolaryngology.

[16]  C. Bower,et al.  Hearing Assessment in Infants and Children: Recommendations Beyond Neonatal Screening , 2009, Pediatrics.

[17]  Guo-jian Wang,et al.  [Mutation of Gap junction protein beta 2 gene and treatment outcome of cochlear implantation in cochlear implantation recipients]. , 2009, Zhonghua yi xue za zhi.

[18]  S. Waltzman,et al.  Predictability of cochlear implant outcome in families , 2009, The Laryngoscope.

[19]  Chuan-Jen Hsu,et al.  Predominance of genetic diagnosis and imaging results as predictors in determining the speech perception performance outcome after cochlear implantation in children. , 2008, Archives of pediatrics & adolescent medicine.

[20]  J. Kronenberg,et al.  Connexin-associated deafness and speech perception outcome of cochlear implantation. , 2006, Archives of otolaryngology--head & neck surgery.

[21]  川崎 聡大.  Using assessment of higher brain functions of children with GJB2-associated deafness and cochlear implants as a procedure to evaluate language development , 2006 .

[22]  B. Fowler,et al.  Genetic Factors That Might Lead to Different Responses in Individuals Exposed to Perchlorate , 2005, Environmental health perspectives.

[23]  A. Hughes,et al.  Auditory Perception and Speech Discrimination After Cochlear Implantation in Patients with Connexin 26 (GJB2) Gene-Related Deafness , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[24]  A. Hughes,et al.  Connexin 26 (GJB2) Gene-Related Deafness and Speech Intelligibility After Cochlear Implantation , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[25]  B. Westerberg,et al.  Systematic review of the etiology of bilateral sensorineural hearing loss in children. , 2004, International journal of pediatric otorhinolaryngology.

[26]  Carolyn J. Brown,et al.  Cochlear Implantation for Children With GJB2‐Related Deafness , 2004, The Laryngoscope.

[27]  M. Wake,et al.  Language and Speech Perception Outcomes in Hearing-Impaired Children with and without Connexin 26 Mutations , 2003, Audiology and Neurotology.

[28]  K. Willecke,et al.  Targeted Ablation of Connexin26 in the Inner Ear Epithelial Gap Junction Network Causes Hearing Impairment and Cell Death , 2002, Current Biology.

[29]  V. Sheffield,et al.  Performance of cochlear implant recipients with GJB2-related deafness. , 2002, American journal of medical genetics.

[30]  N. Matsushiro,et al.  Successful Cochlear Implantation in Prelingual Profound Deafness Resulting From the Common 233delC Mutation of the GJB2 Gene in the Japanese , 2002, The Laryngoscope.

[31]  K. Fukushima,et al.  Better speech performance in cochlear implant patients with GJB2-related deafness. , 2002, International journal of pediatric otorhinolaryngology.

[32]  Joe C. Adams,et al.  Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness , 2000, Medical Electron Microscopy.

[33]  Richard J. H. Smith,et al.  Temporal Bone Histopathology in Connexin 26–Related Hearing Loss , 2000, The Laryngoscope.

[34]  J. Arvedson,et al.  Early identification and intervention for children who are hearing impaired. , 1998, Pediatrics in review.

[35]  K. Arnos,et al.  Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. , 1993, American journal of medical genetics.